Literature DB >> 24210831

Dexamethasone levels predict cortisol response after infant cardiopulmonary bypass.

Sheri S Crow1, William C Oliver2, Jamie A Kiefer3, Melissa R Snyder4, Joseph A Dearani3, Zhuo Li5, Harold M Burkhart3.   

Abstract

OBJECTIVES: We sought to evaluate whether there is variability in blood dexamethasone levels after a standard 1 mg/kg dose of dexamethasone administered before infant cardiopulmonary bypass. We hypothesized that postoperative dexamethasone drug levels are highly variable, and that the infant stress response is related inversely to the amount of dexamethasone measured in the blood.
METHODS: Thirty-two infants (age, ≤365 days) received 1 mg/kg of dexamethasone before cardiopulmonary bypass (CPB) initiation. Blood was analyzed for cortisol, adrenocorticotropin, and interleukin (IL)-6, IL-8, and IL-10 levels after anesthesia induction, after CPB, after intensive care unit (ICU) arrival, and 4, 8, 12, and 24 hours after surgery. Patients were grouped as high dexamethasone (≥15 μg/dL) or low dexamethasone (<15 μg/dL) based on their level at ICU arrival.
RESULTS: Dexamethasone levels varied significantly between the high (n = 22) and low (n = 10) dexamethasone groups throughout the entire postoperative course and were correlated highly with cortisol response. Patients with high dexamethasone levels had postoperative cortisol levels that were lower than their pre-CPB baseline cortisol levels. Cortisol levels remained low throughout the first 24 postoperative hours even after dexamethasone levels neared zero. There were no significant differences between groups in the duration of mechanical ventilation or ICU length of stay.
CONCLUSIONS: Dexamethasone levels are highly variable at ICU arrival, despite standardized 1 mg/kg dosing before CPB initiation.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  20; 41; 41.1; ACTH; CHD; CPB; HCT; ICU; IL; RACHES; Risk Adjustment for Congenital Heart Surgery; adrenocorticotropin; cardiopulmonary bypass; congenital heart disease; hematocrit; intensive care unit; interleukin

Mesh:

Substances:

Year:  2013        PMID: 24210831     DOI: 10.1016/j.jtcvs.2013.09.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Steroids in paediatric heart surgery: eminence or evidence-based practice?

Authors:  Daniel Fudulu; Stafford Lightman; Massimo Caputo; Gianni Angelini
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-04-03

2.  Single Dose Corticosteroid Therapy After Surgical Repair of Fallot's Tetralogy; A Randomized Controlled Clinical Trial.

Authors:  Mohammad Dalili; Ahmad Vesal; Avisa Tabib; Leila Khani-Tafti; Shirin Hosseini; Ziae Totonchi
Journal:  Res Cardiovasc Med       Date:  2015-02-20

Review 3.  Corticosteroids in Pediatric Heart Surgery: Myth or Reality.

Authors:  Daniel P Fudulu; Ben Gibbison; Thomas Upton; Serban C Stoica; Massimo Caputo; Stafford Lightman; Gianni D Angelini
Journal:  Front Pediatr       Date:  2018-04-20       Impact factor: 3.418

4.  Skin-to-Skin Care Is a Safe and Effective Comfort Measure for Infants Before and After Neonatal Cardiac Surgery.

Authors:  Amy J Lisanti; Abigail C Demianczyk; Andrew Costarino; Maria G Vogiatzi; Rebecca Hoffman; Ryan Quinn; Jesse L Chittams; Barbara Medoff-Cooper
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.624

5.  Urinary metabolomics reveals kynurenine pathway perturbation in newborns with transposition of great arteries after surgical repair.

Authors:  Manuela Simonato; Igor Fochi; Luca Vedovelli; Sonia Giambelluca; Cristiana Carollo; Massimo Padalino; Virgilio P Carnielli; Paola Cogo
Journal:  Metabolomics       Date:  2019-10-28       Impact factor: 4.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.